Clinical trial
Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression
NCT00056277 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Placebo Controlled Study of Lamictal in Acute Bipolar Depression
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 27, 2003
- Completion date
- December 14, 2005
- Enrollment
- 150 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.